SSX7 antibody (Middle Region)

Catalog No. ABIN928570

Product Details anti-SSX7 Antibody

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Binding Specificity: Middle Region

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SSX7 antibody is un-conjugated

Application: Western Blotting (WB)

Purification: Purified

Immunogen: SSX7 antibody was raised in rabbit using the middle region of SSX7 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

SSX7 Blocking Peptide, catalog no. 33R-3959, is also available for use as a blocking control in assays to test for specificity of this SSX7 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Alternative Name: SSX7 (SSX7 Products)

Synonyms: SSX family member 7 antibody, SSX7 antibody

Background: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX7 antibody, Anti-SSX7 antibody, synovial sarcoma, X breakpoint 7 antibody.